{"id":727627,"date":"2023-02-01T08:23:30","date_gmt":"2023-02-01T13:23:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/"},"modified":"2023-02-01T08:23:30","modified_gmt":"2023-02-01T13:23:30","slug":"dare-bioscience-to-participate-in-three-february-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/","title":{"rendered":"Dar\u00e9 Bioscience to Participate in Three February Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Feb.  01, 2023  (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ibxMJMu_VxkLbkMhY3TI3LZm5TC0QphEjgxBeFbq4NhGFPI7EDEwZVIrcOalCl5uLhn5IV75HuDOWvVK-bCaHR51Z2p0Vv-bOS778hJHWyoaH0zkhpmozCAEwQXrSNG6zy-hdijm91TAGgWJPhWUwfhKtAWInn_oCeTDLkrJiyj38YV_IM85zF9qgFEMdsd-xQ-xY2zfquW0dnltfR5pxYORYscQWWF2_cFcZoOC3CSGE_IWKk6-DAR1TCN5hqFC\" rel=\"nofollow noopener\" target=\"_blank\">DARE<\/a>), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, the company\u2019s President and CEO, will participate in the following February conferences:<\/p>\n<p align=\"justify\">\n        <strong>2023 BIO CEO &amp; Investor Conference<\/strong><br \/>\n        <br \/>February 6-9, 2023, New York Marriott Marquis, New York, NY<br \/>Company presentation: Tuesday, February 7<sup>th<\/sup> at 3:00 p.m. EST<br \/>Ms. Johnson will be available for one-on-one meetings.<\/p>\n<p align=\"justify\">\n        <strong>SVB Securities Global Biopharma Conference<\/strong><br \/>\n        <br \/>February 13-16, 2023, Virtual<br \/>Members of the company\u2019s management team will be available for one-on-one meetings.<\/p>\n<p align=\"justify\">\n        <strong>3<\/strong><br \/>\n        <sup><br \/>\n          <strong>rd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Women\u2019s Health Innovation Series: Reproductive Health Innovation Summit<\/strong><br \/>\n        <br \/>February 15-16, 2023, Boston Park Plaza, Boston, MA<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:8%;width:8%;min-width:8%\">\u00a0<\/td>\n<td style=\"max-width:92%;width:92%;min-width:92%\">\n            <strong>\u00a0 Panel Presentation:<\/strong><br \/>\n            <strong><br \/>\n              <em> Contraception: Traversing the Lesser-Known Male Space<\/em><br \/>\n            <\/strong><br \/>\n            <br \/>\u00a0 Thursday, February 16<sup>th<\/sup> at 3:30 p.m. EST <br \/>\u00a0 Moderator: Heather Vahdat, Executive Director, Male Contraceptive Initiative<br \/>\u00a0 Kevin Eisenfrats, Co-Founder &amp; CEO, Contraline<br \/>\u00a0 Stasia Obremskey, Managing Director, RH Capital<br \/>\u00a0 Sabrina Martucci Johnson, President &amp; CEO, Dar\u00e9 Bioscience<br \/>\u00a0 Akash Bakshi, CEO, YourChoice Therapeutics<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About Dar\u00e9 Bioscience<\/strong><br \/>\n        \n      <\/p>\n<p align=\"justify\">Dar\u00e9 Bioscience is a biopharmaceutical company committed to advancing innovative products for women\u2019s health. The company\u2019s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that prioritize women&#8217;s health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, vaginal, and reproductive, menopause, and sexual health.<\/p>\n<p align=\"justify\">Dar\u00e9\u2019s first FDA-approved product, XACIATO<sup>TM<\/sup> (clindamycin phosphate) vaginal gel, 2% is a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. XACIATO is a clear, colorless, viscous gel, to be administered once intravaginally as a single dose. Dar\u00e9\u2019s portfolio also includes potential first-in-category candidates in clinical development: Ovaprene<sup>\u00ae<\/sup>, a novel, hormone-free monthly intravaginal contraceptive whose\u00a0U.S.\u00a0commercial rights are under a license agreement with Bayer; Sildenafil Cream, 3.6%, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra<sup>\u00ae<\/sup>; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for hormone therapy following menopause. To learn more about XACIATO, Dar\u00e9\u2019s full portfolio of women\u2019s health product candidates, and Dar\u00e9\u2019s mission to deliver differentiated therapies for women, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n-J2AmjQsj4GuC3GnwUILJ0y1d5h9JSTwypyPgBdjoT1a_1uni57wdh092JR929YpSkNavm2hhJRPPJ9zBmG7x3fhtyX_GVpj4lLzG9PFcM=\" rel=\"nofollow noopener\" target=\"_blank\">www.darebioscience.com<\/a>.<\/p>\n<p align=\"justify\">Dar\u00e9 may announce material information about its finances, product and product candidates, clinical trials and other matters using the Investors section of its website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0YWdleNN7KBdXQyPnJZnEdmsOtaXW1As3QXfCZ9EJ4oC-JjGOP18DcXVsP_0tovbKSXt6zkWBd1Rnk7jCpD5SeK8PhsH0awGesbBVwv9ozc=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/ir.darebioscience.com<\/a>), SEC filings, press releases, public conference calls and webcasts. Dar\u00e9 will use these channels to distribute material information about the company, and may also use social media to communicate important information about the company, its finances, product and product candidates, clinical trials and other matters. The information Dar\u00e9 posts on its investor relations website or through social media channels may be deemed to be material information. Dar\u00e9 encourages investors, the media, and others interested in the company to review the information Dar\u00e9 posts in the Investors section of its website and to follow these Twitter accounts: @SabrinaDareCEO and @DareBioscience. Any updates to the list of social media channels the company may use to communicate information will be posted in the Investors section of Dar\u00e9\u2019s website.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Investors on behalf of Dar\u00e9 Bioscience, Inc.:<br \/>Lee Roth <br \/>Burns McClellan<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dk15EoLeDLsPVg-Iuq4aD7MURLxXKt_epQyn0v5WcM-ZmW-XcQhP_ukrc6cJ0_CEcXUdPMShVKv2zlGuJk9FBw==\" rel=\"nofollow noopener\" target=\"_blank\">lroth@burnsmc.com<\/a><br \/>212.213.0006<\/p>\n<p>OR<\/p>\n<p>Media on behalf of Dar\u00e9\u00a0Bioscience, Inc.:<br \/>Jake Robison<br \/>Evoke Canale <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TaYVDxfMe5Ps5w3y3LxDwvcap39PcQuc-8a1-d3SVngGrSjQTxzjQfWLWnH857YOCx8WtV5iwziI-oTt1wmFGd8lRG0yN1RPtTHArE4yDUqbYVXeq8IYCkIfdviojLAZ\" rel=\"nofollow noopener\" target=\"_blank\">jake.robison@evokegroup.com<\/a><br \/>619.849.5383<\/p>\n<p>Source: Dar\u00e9 Bioscience, Inc.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZmVmMzZmODMtMzcyMC00ZmNkLWE3OTAtMGIwYjRlOGYxYzViLTEwMTk5Mzc=\/tiny\/Dar-Bioscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, the company\u2019s President and CEO, will participate in the following February conferences: 2023 BIO CEO &amp; Investor Conference February 6-9, 2023, New York Marriott Marquis, New York, NYCompany presentation: Tuesday, February 7th at 3:00 p.m. ESTMs. Johnson will be available for one-on-one meetings. SVB Securities Global Biopharma Conference February 13-16, 2023, VirtualMembers of the company\u2019s management team will be available for one-on-one meetings. 3 rd Annual Women\u2019s Health Innovation Series: Reproductive Health Innovation Summit February 15-16, 2023, Boston Park Plaza, Boston, MA \u00a0 \u00a0 Panel Presentation: Contraception: Traversing the Lesser-Known Male Space \u00a0 Thursday, February &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dar\u00e9 Bioscience to Participate in Three February Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727627","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dar\u00e9 Bioscience to Participate in Three February Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dar\u00e9 Bioscience to Participate in Three February Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, the company\u2019s President and CEO, will participate in the following February conferences: 2023 BIO CEO &amp; Investor Conference February 6-9, 2023, New York Marriott Marquis, New York, NYCompany presentation: Tuesday, February 7th at 3:00 p.m. ESTMs. Johnson will be available for one-on-one meetings. SVB Securities Global Biopharma Conference February 13-16, 2023, VirtualMembers of the company\u2019s management team will be available for one-on-one meetings. 3 rd Annual Women\u2019s Health Innovation Series: Reproductive Health Innovation Summit February 15-16, 2023, Boston Park Plaza, Boston, MA \u00a0 \u00a0 Panel Presentation: Contraception: Traversing the Lesser-Known Male Space \u00a0 Thursday, February &hellip; Continue reading &quot;Dar\u00e9 Bioscience to Participate in Three February Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-01T13:23:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dar\u00e9 Bioscience to Participate in Three February Conferences\",\"datePublished\":\"2023-02-01T13:23:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/\"},\"wordCount\":559,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/\",\"name\":\"Dar\u00e9 Bioscience to Participate in Three February Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=\",\"datePublished\":\"2023-02-01T13:23:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-in-three-february-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dar\u00e9 Bioscience to Participate in Three February Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dar\u00e9 Bioscience to Participate in Three February Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Dar\u00e9 Bioscience to Participate in Three February Conferences - Market Newsdesk","og_description":"SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, the company\u2019s President and CEO, will participate in the following February conferences: 2023 BIO CEO &amp; Investor Conference February 6-9, 2023, New York Marriott Marquis, New York, NYCompany presentation: Tuesday, February 7th at 3:00 p.m. ESTMs. Johnson will be available for one-on-one meetings. SVB Securities Global Biopharma Conference February 13-16, 2023, VirtualMembers of the company\u2019s management team will be available for one-on-one meetings. 3 rd Annual Women\u2019s Health Innovation Series: Reproductive Health Innovation Summit February 15-16, 2023, Boston Park Plaza, Boston, MA \u00a0 \u00a0 Panel Presentation: Contraception: Traversing the Lesser-Known Male Space \u00a0 Thursday, February &hellip; Continue reading \"Dar\u00e9 Bioscience to Participate in Three February Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-01T13:23:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dar\u00e9 Bioscience to Participate in Three February Conferences","datePublished":"2023-02-01T13:23:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/"},"wordCount":559,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/","name":"Dar\u00e9 Bioscience to Participate in Three February Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=","datePublished":"2023-02-01T13:23:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDI4OSM1Mzg0MzcwIzIwMDgzNjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-in-three-february-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dar\u00e9 Bioscience to Participate in Three February Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727627"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727627\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}